Literature DB >> 31802981

Current Treatment of Thrombocytopenia in Chronic Liver Disease.

Sammy Saab1.   

Abstract

Entities:  

Year:  2019        PMID： 31802981      PMCID： PMC6883735     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.

Authors:  Hisashi Hidaka; Masayuki Kurosaki; Hironori Tanaka; Masatoshi Kudo; Seigo Abiru; Takumi Igura; Toru Ishikawa; Masataka Seike; Takayuki Katsube; Toshimitsu Ochiai; Kazuhiro Kimura; Takahiro Fukuhara; Takeshi Kano; Tsutae Nagata; Katsuaki Tanaka; Mineo Kurokawa; Kazuhide Yamamoto; Yukio Osaki; Namiki Izumi; Michio Imawari
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-28       Impact factor: 11.382

Review 2.  Thrombocytopenia in chronic liver disease.

Authors:  Markus Peck-Radosavljevic
Journal:  Liver Int       Date:  2016-12-27       Impact factor: 5.828

Review 3.  Management of Thrombocytopenia in Patients with Chronic Liver Disease.

Authors:  Sammy Saab; Robert S Brown
Journal:  Dig Dis Sci       Date:  2019-04-22       Impact factor: 3.199

4.  Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Authors:  Norah Terrault; Yi-Cheng Chen; Namiki Izumi; Zeid Kayali; Paul Mitrut; Won Young Tak; Lee F Allen; Tarek Hassanein
Journal:  Gastroenterology       Date:  2018-05-17       Impact factor: 22.682

5.  Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Chunlu Li; Xiaoxuan Li; Feihong Huang; Jing Yang; Anguo Wu; Long Wang; Dalian Qin; Wenjun Zou; Jianming Wu
Journal:  Front Pharmacol       Date:  2019-07-26       Impact factor: 5.810

6.  Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).

Authors:  Markus Peck-Radosavljevic; Krzysztof Simon; Angelo Iacobellis; Tarek Hassanein; Zeid Kayali; Albert Tran; Mihaly Makara; Ziv Ben Ari; Marius Braun; Paul Mitrut; Sheng-Shun Yang; Meral Akdogan; Mario Pirisi; Ajay Duggal; Toshimitsu Ochiai; Tomoko Motomiya; Takeshi Kano; Tsutae Nagata; Nezam Afdhal
Journal:  Hepatology       Date:  2019-03-15       Impact factor: 17.425
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.